SEARCH

SEARCH BY CITATION

References

  • 1
    U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network: Annual Report 2000. Transplant Data: 1990–1999. Rockville, MD, Richmond, VA: U.S. Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, United Network for Organ Sharing; 2000.
  • 2
    Stegall MD, Dean PG, McBride MA, Wynn JJ, Organ Procurement and Transplantation Network/ United Network for Organ Sharing Kidney/ Pancreas Transplantation Committee. Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch era. Transplantation 2002; 74: 670675.
  • 3
    Schweitzer E, Wilson JS, Fernandez-Vina M et al. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation 2000; 70: 15311536.
  • 4
    Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70: 887895.
  • 5
    Tyan D, Li V, Czer L, Trento A, Jordan S. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994; 57: 553562.
  • 6
    Glotz D, Antoine C, Julia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulin. Am J Transplant 2002; 2: 758760.
  • 7
    Jordan S, Tyan D, Czer L, Toyoda M. Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ transplant recipients. Pediatr Transplant 1998; 2: 92105.
  • 8
    Gloor JM, Lager DJ, Moore SB et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75: 971977.
  • 9
    Gebel HM, Bray RA. Sensitization and sensitivity: defining the unsensitized patient. Transplantation 2000; 69: 13701374.
  • 10
    Scornik JC, Clapp W, Patton PR et al. Outcome of kidney transplants in patients known to be crossmatch positive. Transplantation 2001; 71: 10981102.
  • 11
    Karpinski M, Rush D, Jeffery J et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 2001; 12: 28072814.
  • 12
    Kerman RH, Susskind B, Buelow R et al. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection. Transplantation 1996; 62: 201205.
  • 13
    Alexandre GPJ, Squifflet JP, De Bruyere M et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 1985; 17: 138143.
  • 14
    Sawada T, Fuchinoue S, Teraoka S. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation 2002; 74: 12071210.
  • 15
    Scornik JC, Salomon DR, Lim PB, Howard RJ, Pfaff WW. Posttransplant antidonor antibodies and graft rejection. Transplantation 1989; 47: 287290.
  • 16
    Piazza A, Poggi E, Borrelli L et al. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow-cytometric techniques. Transplantation 2001; 71: 11061112.
  • 17
    Piazza A, Borrelli L, Monaco PI et al. Posttransplant donor-specific antibody characterization and kidney graft survival. Transplant Int 2000; 13 (Suppl. 1): S439S443.
  • 18
    Martin S, Dyer PA, Mallick NP, Gokal R, Harris R, Johnson RWG. Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome. Transplantation 1987; 44: 5053.
  • 19
    Kozlowski T, Tibell A, Morpurgo E, Sundberg B, Sundin U, Groth C. Suppression of immunoglobulin resynthesis after plasmapheresis: efficacy of various immunosuppressive drugs – a study in rats. Transplant Proc 1995; 27: 35453546.